Related Experiment Videos
Nicotine intake and dependence in Swedish snuff takers
H Holm1, M J Jarvis, M A Russell
1Department of Psychiatry, Kalmar Hospital, Sweden.
Psychopharmacology
|January 1, 1992
Summary
Swedish moist oral snuff users absorb nicotine rapidly, with peak blood levels similar to cigarette smokers. This suggests nicotine intake, not combustion products, may drive tobacco-related cardiovascular risks.
Area of Science:
- Pharmacology
- Toxicology
- Epidemiology
Background:
- Swedish moist oral snuff is a tobacco product with unique nicotine delivery.
- Understanding nicotine pharmacokinetics in snuff users is crucial for assessing tobacco-related health risks.
- Distinguishing the effects of nicotine from combustion products is key to public health research.
Purpose of the Study:
- To quantify nicotine and cotinine absorption in users of Swedish moist oral snuff.
- To compare nicotine intake and subjective dependence between snuff users and cigarette smokers.
- To inform epidemiological studies on the cardiovascular risks associated with smokeless tobacco.
Main Methods:
- Two studies were conducted: one examining acute nicotine absorption from a single pinch of snuff, and another assessing habitual use in snuff takers and cigarette smokers.
- Plasma nicotine and cotinine concentrations were measured at various time points after tobacco use.
- Subjective levels of dependence were assessed using self-report measures.
Main Results:
- Nicotine absorption from a single pinch of snuff was rapid, with peak plasma concentrations reached shortly after use.
- Peak blood nicotine levels were similar between habitual snuff takers and cigarette smokers.
- Habitual snuff users tended to have higher plasma cotinine levels compared to cigarette smokers.
- Subjective dependence levels were comparable between the two groups.
Conclusions:
- Swedish moist oral snuff provides significant nicotine delivery, comparable to cigarette smoking.
- The absence of combustion products in snuff allows for clearer investigation into nicotine's role in cardiovascular risks.
- Further epidemiological research on Swedish snuff users is warranted to elucidate the specific health impacts of nicotine versus other tobacco constituents.